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Streptomycin 
A Review of the Literature 
E. H. COLES*, D.V.M., M.S. 
'-! TREPTOMYCIN is an antibacterial 
() agent of relatively low toxicity which 
was isolated by Selman A. Waksman in 
1944 from certain strains of the soil ac-
tinomycete, Streptomyces grieseus. 
One of the most outstanding properties 
of this antibacterial agent is its ability 
to inhibit the growth of the Gram-negative 
and acid-fast organisms. It has also been 
found to inhibit the growth of certain 
Gram-positive organisms but not to such 
an extent as to replace penicillin for the 
treatment of conditions caused by this 
group of bacteria. 
Although there has been a great deal 
of research in connection with the organ-
isms causing disease in humans, there 
have been few published reports as to the 
effect of streptomycin for the treatment 
of animals. However, many of the reports 
do contain material which will be of in-
terest to the veterinarian. A large number 
of organisms which have been studied 
in vitro are pathogenic to the domestic 
animals as well as to man. 
In Vitro Antibacterial Activity: The 
complete range of the activity of strepto-
mycin has not yet been determined. Many 
organisms which are found to be patho-
genic to domestic animals have been test-
ed in vitro and, although the results are 
not always duplicated when tested in vivo, 
such results do indicate a trend towards 
streptomycin susceptibility. Results of the 
several in vitro determinations are dem-
onstrated in Table 1. 
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It is ob.vious from Table 1 that there is 
a great range of streptomycin suscepti-
bility exhibited by the various organisms. 
In addition to the species variability that 
exists, a great deal of strain variability 
has been noted (5, 7). Waksman (3) 
makes the statement, "The sensitivity of 
a given culture of an organism to strep-
tomycin is characteristic not only of the 
organism but of the strain as well." 
Not only is strept.omycin strongly bac-
teriostatic against Gram-negative and 
Gram-positive bacteria, but it also exhi-
bits a marked bactericidal effect as is 
pointed out in Table 2, (5). 
It will be noted in Table 2, that in the 
absence of any streptomycin, growth was 
quite rapid in all 3 cultures. When the 
organisms were incubated in the presence 
of 1 microgram of the antibiotic per ml., 
the numbers were reduced. The addition 
of 5 micrograms (units) per ml. brought 
about nearly complete destruction of the 
cells of the cultures W 1 and W 2 while the 
reduction of Strain R. (the resistant 
strain) was appreciably less. 
Santivanez (8) has reported that a 
concentration of 12.5 micrograms per m!. 
sterilized a broth culture of Pasteurella 
avicida in 4 hours. A concentration of 
6.25 micrograms halted the growth in 12 
hours. A culture of Brucena abortus was 
found to be completely inhibited by 25 
micrograms per m!. at the end of 12 hours. 
Salmonella pullOrtLm was completely in-
hibited by a concentration of 12.5 micro-
grams at the end of 24 hours. 
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TABLE 1 
RANGES IN SUSCEPTIBILITY OF BACTERIA TO STREPTOMYCIN 
Range-Micrograms I 
Organism Per m!. References 
----------------- ---- ." ---------- ----1- ------
Aerobacter aerogenes. . . . . . . . . . . . . . . . . . . . . . 0.5 - 2.5 1, 2 
Bacillus anthracis. . . . . . ...... I O. 375 I 3 
Brucella militensis. . . . . . . . . .. 'j 0.5 - 3.75 I 3 
Brucella ahortus. . . . . . . O. 5 3 
Brucella suis. . . . . . . . . . . . . . . . . . . . . . . ...... " 0.5 1 3 
Clostridium septicum. . . . . . . . . . . . . . . . . . . . . . . . > 105 1 2 
Costridium telani. . . . . . . . . . . . . '. '. '. '.1 »11 0044 22 Clostridium welchii . ..... . 
Erysipelothrix rhusiopathiae .......................... 1 2.5 -10.0 4,7 
Escherichia coli. . . . . . . . . . . . . . . . . . . . . . . . . . . . '1 0.3 - 3.75 5 
Listerella manocytogenes. . . . . . . . 2. 5 1 
Klebsiella pneumoniae. . . . . . . . . . . . . . . . . . . . . . 0 . 625- 8.0 6 
Malleomyces mallei... . . ..... .. 1.0 >10 3,7 
Mycobacterium avium. . . . . I 10 . 0 4 
Pasteurella auiseptica. . . . . . 0.; -15 . 0 3, 7, 8 
Pasteurella tularensis. . . . . . . . . . . . . 0.15 - 0.3 I 3 
Proteus vulgaris. . . . . . . . . . . . . . . I 0 . 4 - 3.0 1 5 
Pseudomonas aeruginosa. . . '.1 2.5 -25.0 1, 4 
Salmonella aertrycke. . . . . . 4.0 -10.0 1, 2 
Salmonella enteritidis. . . . . . . I 0.5 -10.0 2, 7 
Staphylococcus aureus. 0.5 > 16 1 2 
Actinomyces havis. . . . : . : : I 3.7 5 3 
Bacteria may acquire a resistance to 
streptomycin quite rapidly; Buggs et al 
(9) were among the first to point out this 
fact. They reported a case in which 
Proteus vulgaris, when first isolated, was 
found to be sensitive to 2 micrograms per 
ml. and when re-isolated after the patient 
had been treated with streptomycin was 
found to require 8 micrograms to inhibit 
growth. The same was found to be true 
with a culture of Pseudomonas aerugin-
osa. When tested before treatment it was 
sensitive to 32 micrograms and after treat-
ment the organism was resistant to 256 
micrograms per ml. Such increases have 
also been reported with the acid-fast 
Mycobacterium tuberculosis (10) . Re-
sistance of some strains has ben reported 
to increase 500 to 1,000 fold. Increases in 
resistance to the antibiotic undoubtedly 
will playa major role in the use of strep-
tomycin. 
Toxicity and Efficacy of Streptomycin 
in Animals: Studies on the absorption 
and excretion of streptomycin indicate 
that when administered parenterally, it 
behaves much like penicillin in that both 
antibiotics are absorbed and excreted 
quite rapidly. Therapeutic blood levels 
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are easily obtained by intravenous, subcu-
taneous or intramuscular injections but 
oral administration has been found to pro-
duce only a very low blood level (2). 
The toxicity of streptomycin has been 
found to be quite low. This is especially 
true of the more purified preparations. 
When toxic results have been noted, they 
reveal themselves as histamine-like re-
actions, the visable reactions in mice be-
ing increased activity, marked dyspnea 
and occasionally respiratory failure. This 
type of toxicity is undoubtedly due to the 
presence of impurities, as such manifesta-
tions are absent when pure preparations 
are used (2). 
Another toxic effect, which is especial-
ly pronounced in monkeys, is observed 
following the prolonged administration of 
large doses. This occurs as a fatty infiltra-
tion of the liver and sometimes the kid-
ney. However, this type of pathology has 
been shown to be reversible and not the 
first step of a progressive degeneration. 
This type of toxicity is not ordinarily noted 
in rats or mice (11). 
Some of the first animal experiments 
were carried out with a crude prepara-
tion of the drug (12). In order to protect 
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TABLE 2 
BACTERIAL ACTION OF STREPTOMYCIN UPON Proteus Vulgaris * 
Streptomycin Micrograms 
Per m!. 
0 ... . .... . .. . . . . .. . . . . . . .. . .. . . 
1. . . . . . . . . . . . . ....... . . . . .. . 
5 . . .... .. .. . ...... . . . .. .. .... . 
25 ..... . . . ... ... . .. . .. .... . . . 
* Number of cells in millions per m!. 
t 1 colony on plate from 1 :1',000 di!. 
; 7-8 colonies on a plate from 1: 1 0 di!. 
Pro vulgaris 
Wi 
375 
0.01 
ot 
o 
18-20 gram mice infected with Salmonella 
schottmulleri, 6.4 mg. of crude material 
was required (the raw material assayed 
at approximately 30 micrograms per mg.). 
Streptomycin was found to be quite ac-
tive in combatting experimental tularemia 
in mice (6). In one experiment, in which 
30 control mice died of tularemia within 
4 days, 30 other mice which received 
1,000 micrograms daily for 10 days all sur-
vived the infection. 
In experimental infections with Kleb-
siella ,Pneumoniae, streptomycin also ex-
hibited a very marked protective effect 
(13). When doses of 185-500 micrograms 
were administered daily over a period of 
2 or 3 days, 42 of 49 mice survived intra-
peritoneal inoculation of 1,000 to 10,000 
lethal doses of the pathogen. All of the 
49 untreated control mice died when the 
organisms were administered intra-ab-
dominally. 
Development of the human strain of 
Mycobacterium tuberculosis in guinea 
pigs can be controlled by streptomycin. 
On the basis of an arbitrarily established 
index of infection, 100 represented the 
maximum possible amount of tuberculo-
sis. The untreated control animals which 
were sacrificed at 61 days exhibited an 
index of 67 as contrasted to an index of 
5.8 for those which had received strep-
tomycin. In a second experiment, the 
values were 81.9 for the untreated and 2.8 
for the treated animals. The daily ad-
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Pro vulgaris 
W2 
615.0 
0.65 
ott 
o 
Pr. vulgaris 
Strain R . 
560.0 
190.0 
9.0 
3 .13 
ministration of streptomycin varied from 
1,387 to 6,000 micrograms (14) . 
Streptomycin has also been found to 
exert a repressive effect in experimental 
infections with Borrelia novyi and Lep-
tospira icterohaemorrhagiae (15). 
Fig. 1. Streptomycin in blood-agar plate exhihit-
ing complete inhibition of Staphylococcus aureus. 
The clear zone is hemolysis but no colonies are 
present. 
Live, Sperling and Stubbs, (16), used 
streptomycin in the treatment of experi-
mental brucellosis of guinea pigs. In one 
experiment they used a total of 80 ani-
mals which were injected with 20,000 
Brucella abortus organisms of a highly 
virulent strain. Forty of the animals were 
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treated with 5,000 micrograms of strepto-
mycin daily, administered subcutaneous-
ly in 5 equal doses at 4 hour intervals. At 
the end of 27 days all of the animals were 
autopsied. In all of the untreated animals, 
there was an agglutination titer of 1: 100 
or higher and a positive culture was made 
from the inguinal lymph nodes, liver and 
spleen of all untreated animals. In the' 
treated animals, there were only 4 that 
showed positive cultures from all 3 
sources. The agglutination titer of the 
treated animals was appreciably less; 
there were 2 animals with a titer of 1: 100 
or greater, 4 with a titer of 1: 50 and 1 
animal with a titer of 1: 25. 
Benson (17) has reported that strep-
tomycin is an effective antibiotic against 
Salmonella pullorum in chicks. The or-
ganisms were administered intraperi-
tone ally and also given in the water. 
Streptomycin was administered begin-
ning, in one experiment, 16 hours after 
inoculation. Doses of 2,500 micrograms 
were administered at varying intervals 
Fig. 2. Streptomycin in blood-agar plate show-
ing no inhibition of Stanhylococcus au reus. 
up to 72 hours. Of the 26 treated chicks, 
only 3 died of the disease. Twenty-six 
other chicks were inoculated with the or-
ganisms but not with streptomycin; of 
these, 23 died. 
Summary and Conclusions: It is evi-
dent from the present data that very little 
work with streptomycin in treating animal 
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diseases has accumulated. It is impossible, 
therefore, to make any conclusions at the 
present time as to role streptomycin will 
play in veterinary medicine. 
It is apparent, from the existing infor-
mation, that streptomycin may have ap-
plication in the treatment of animal dis-
eases caused by some of the Gram-nega-
tive organisms. 
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Ground pork or beef which is to be 
frozen for preservation should not be 
salted, as salt stimulates oxidation re-
sulting in rancidity; sage, pepper, mace 
and ginger seem to have an opposite ef-
fect. 
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